The evaluation study of clinical potentials using 320-row detector computed tomography (Aquilion ONE).
Not Applicable
- Conditions
- Malignant tumor
- Registration Number
- JPRN-UMIN000001965
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1)A patient has the history of the allergy to the contrast materials for computed tomography. 2)The patient by whom consent was not acquired at the main point of this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of 320-row area detector computed tomography in the image diagnosis of a malignant tumor.
- Secondary Outcome Measures
Name Time Method Development of the new image-diagnosis procedure based on fourth dimension image data.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does 320-row detector CT enhance in malignant tumor diagnostics?
How does area detector CT compare to standard imaging in malignant tumor staging and treatment monitoring?
What biomarkers are associated with improved outcomes using Aquilion ONE in cancer patients?
What adverse events are linked to 320-row detector CT in oncology and how are they managed?
Are there combination therapies or competitor imaging technologies relevant to JPRN-UMIN000001965 study?